Cadre Holdings

CDRE · NYSE

$27.05−$0.02 (−0.07%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $27.07

CDRE analyst rating

BuyConsensus of 2 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy2
Hold0
Underperform0
Sell0

12-month price target · 8 analysts

Average $48.96 (+81.0% upside)

Low: $43.43
Now: $27.05
High: $65.10

Upgrades and downgrades

The latest rating actions, newest first

CDRE analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 13, 2026	Maintains	Overweight	$45.00 → $35.00	27%
DA Davidson	Aug 10, 2026	Maintains	Overweight	$40.00 → $43.00	27%
Roth Capital	Aug 10, 2026	Maintains	Buy	$40.00 → $43.00	39%
JP Morgan	Aug 7, 2026	Maintains	Overweight	$40.00 → $45.00	27%
JP Morgan	Jul 27, 2026	Initiates	Overweight	$40.00	27%
Roth Capital	Feb 3, 2026	Maintains	Buy	$49.00 → $50.00	39%

The case for and against

Updated Nov 30, 2024

Bull case

Cadre Holdings Inc has demonstrated robust financial health, highlighted by a strong increase in gross margin, which rose by 70 basis points to 39.9%, despite a less favorable product mix. The demand for the company’s products is underscored by a significant backlog growth of $8.8 million since the beginning of 2023, reaching a total of $126.7 million, indicating sustained market interest. Furthermore, Cadre Holdings has successfully leveraged its competitive advantages in the public safety market, achieving substantial CFO and free cash flow increases of 59% and 54% respectively, which supports its strategic acquisitions and positions the company for ongoing growth in a stable industry spending environment.

Bear case

Cadre Holdings Inc. experienced a decline in AEBITDA of 7.6% despite a slight sales increase of 0.8%, contributing to a decrease in the AEBITDA margin from 18.1% to 16.6%. The shifting political landscape in the U.S. is anticipated to exert downward pressure on the defense budget, which could hinder future sales growth for the company. Additionally, challenges in retaining key personnel may affect Cadre's operational efficiency and its capability to execute its growth strategy effectively.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.